VosT, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2012; 380: 2163–2196.
2.
LaunerBMcVaryKRickeW, et al. The rising worldwide impact of benign prostatic hyperplasia. BJU Int. Epub ahead of print 30 October 2020. DOI: 10.1111/bju.15286.
3.
HashimHAbramsP.Transurethral resection of the prostate for benign prostatic obstruction: will it remain the gold standard?Eur Urol2015; 67: 1097–1098.
4.
HuangSTsaiCTsengC, et al. Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: systematic review and network meta-analysis. BMJ2019; 397, l5919.
5.
RassweilerJTeberDKuntzR, et al. Complications of Transurethral Resection of the Prostate (TURP)—Incidence, Management, and Prevention, Eur Urol2006; 50: 969–980.
6.
GilfrichCMayMFahlenbrachC, et al. Surgical Reintervention rates after invasive treatment for lower urinary tract symptoms due to benign prostatic syndrome: a comparative study of more than 43,000 patients with long-term followup. J Uro2021; 205: 855–863.
7.
RoosN, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. New Eng J Med1989; 320: 1120–1124.
8.
EredicsK, et al. Reoperation rates and mortality after transurethral and open prostatectomy in a long-term nationwide analysis: have we improved over a decade?Urology2018; 118: 152–157.
9.
JohnstonM, et al. The ‘Urological Stethoscope’: an essential aide for the modern benign prostatic hyperplasia specialist?BJU Int2020; 125: 632–633.
10.
SrinivasanAWangR.An update on minimally invasive surgery for benign prostatic hyperplasia: techniques, risks, and efficacy. World J Men’s Health2020; 38: 402.
11.
ChristidisD, et al. Minimally invasive surgical therapies for benign prostatic hypertrophy: the rise in minimally invasive surgical therapies. Prostate Int2017; 5: 41–46.
12.
NeoTractI.UroLift®: FDA Cleared BPH Treatment for Enlarged Prostate, Urolift.com, https://www.urolift.com/ (2021, accessed 27 February 2021).
PorpigliaF, et al. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up, BJU Int2015; 116: 278–287.
RoehrbornCG, et al. Five-year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol2017; 24: 8802
17.
PereraM, et al. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol2015; 67: 704
18.
PorpigliaF, et al. 3-year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction. BJU Int2018; 122: 106–112
19.
JohnstonM, et al. (2020) Rezum water vapour therapy: promising early outcomes from the first UK series. BJU Int2020; 126: 557–558.
20.
McVaryKRogersTRoehrbornC.Rezūm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology2019; 126: 171–179.
21.
MillerLE, et al. Surgical reintervention rate after prostatic urethral lift: systematic review and meta-analysis involving over 2,000 patients. J Urol2020; 204: 1019–1026.
22.
ThomasJA, et al. A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-year outcomes of the GOLIATH Study. Eur Urol2016; 69: 94
23.
Al-AnsariA, et al. GreenLight HPS 120-W Laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol2010; 58: 349–355.
24.
ThangasamyI, et al. (2012) Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol62: 315–323.
25.
ZhouY, et al. Greenlight high-performance system (HPS) 120-W laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a meta-analysis of the published results of randomized controlled trials, Lasers Med Sci2016; 31: 485–495.
26.
FraundorferMGillingP.Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol1998; 33: 69–72.
27.
VincentMGillingP. HoLEP has come of age. World J Urol2014; 33: 487–493.
28.
AhoT, et al. Anatomical endoscopic enucleation of the prostate: the next gold standard? Yes!Andrologia2020; 52: e13643.
29.
Gómez-SanchaF.The constant search for the greater good: evolving from TURP to anatomic enucleation of the prostate is a safe bet. World J Oncol. Epub ahead of print 24 February 2021. DOI: 10.1007/s00345-021-03637-1.
ParsonsJKDahmPKöhlerTS, et al. Surgical management of lower urinary tract symptoms attributed to Benign pro-static hyperplasia: AUA Guideline Amendment 2020. J Urol2020; 204:799–804
32.
YinL, et al. Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol2013; 27: 604–611.
33.
TanA, et al. Meta-analysis of holmium laser enucleationversus transurethral resection of the prostate for symptomatic prostatic obstruction. Brit J Surg2007; 94: 1201–1208.
34.
CornuJ, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol2015; 67: 1066–1096.
35.
ElshalA, et al. Holmium laser enucleation of the prostate for treatment for large-sized benign prostate hyperplasia; is it a realistic endourologic alternative in developing country?World J Oncol2015; 34: 399–405.
36.
MaoyinL, et al. Endoscopic enucleation versus open prostatectomy for treating large benign prostatic hyperplasia: a meta-analysis of randomized controlled trials. PLoS One2015; 10: e0121265
37.
LinY, et al. Transurethral enucleation of the prostate versus transvesical open prostatectomy for large benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. World J Oncol2015; 34: 1207–1219.
38.
JonesP, et al. Holmium laser enucleation versus simple prostatectomy for treating large prostates: results of a systematic review and meta-analysis. Arab J Urol2016; 14: 50–58.
39.
LourencoT, et al. Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials. BMJ2008; 337: a449–a449
40.
NasproR, et al. Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol2006; 50: 563–568.
41.
Gomez SanchaF, et al. Common trend: move to enucleation – Is there a case for GreenLight enucleation? Development and description of the technique. World J Oncol2014; 33: 539–547.
42.
ElshalA, et al. GreenLight™ Laser (XPS) photoselective vapo-enucleation versus holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic hyperplasia: a randomized controlled study. J Urol2015; 193: 927–934.
43.
MisraïV, et al. Comparison between open simple prostatectomy and green laser enucleation of the prostate for treating large benign prostatic hyperplasia: a single-centre experience. World J Oncol2018; 36: 793–799.
44.
XiaoK, et al. Enucleation of the prostate for benign prostatic hyperplasia thulium laser versus holmium laser: a systematic review and meta-analysis. Lasers Med Sci2019; 34: 815–826.
45.
HartungFKowalewskiKFHardenbergJ, et al. (2021) Holmium Versus Thulium Laser Enucleation of the Prostate: A Systematic Review and Meta-analysis of Randomized Controlled Trials, Eur Urol Focus. Epub ahead of print April 2021. DOI: 10.1016/j.euf.2021.03.024.
46.
WaniM, et al. Is thulium laser enucleation of prostate an alternative to Holmium and TURP surgeries: a systematic review?Turkish J Urol2020; 46: 419–426.
47.
HerrmannT.Enucleation is enucleation is enucleation is enucleation. World J Oncol2016; 34: 1353–1355.
48.
AntunesA, et al. Holmium laser enucleation of the prostate simulation: analysis of realism and level of difficulty by holmium laser enucleation of the prostate-naïve urologists. Urology2019; 125: 34–39.
49.
AhoTHerrmannT.Description of a modular mentorship programme for holmium laser enucleation of the prostate. World J Oncol2014; 33: 497–502.
50.
Dell’OglioPGoossensMMontorsiF., et al. Definition of a structured training curriculum for holmium laser enucleation of the prostate. Eur Urol Open Sci2020; 19: e1262–e1263.
51.
SandhuJ, et al. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol2005; 19: 1196–1198.
52.
RuszatR, et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol2007; 51: 1031–1041.
53.
ChungD, et al. Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia. J Urol2011; 186: 977–981.
54.
National Institute for Health and Care Excellence. Lower urinary tract symptoms in men: management, Guidance and guidelines, NICE, https://www.nice.org.uk (2020).
55.
ElshalA, et al. Randomized trial of bipolar resection vs. holmium laser enucleation vs. Greenlight laser vapo-enucleation of the prostate for treatment of large sized benign prostate obstruction; 3-years outcomes. BJU Int. 2020; 126: 731–738.
56.
MallingB, et al. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Radiol2018; 29: 287–298.
57.
AbtD, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ2018; 361: k2338
58.
BhatiaS, et al. Prostate artery embolization in patients with prostate volumes of 80 mL or more: a single-institution retrospective experience of 93 patients. J Vasc Interv Radiol2018; 29: 1392–1398.
59.
AbtD, et al. Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-yr outcomes of a randomised, open-label, single-centre trial. Eur Urol. Epub ahead of print 19 February 2010. DOI: 10.1016/j.eururo.2021.02.008.
60.
Gondran-TellierB, et al. Efficacy and safety of surgery for benign prostatic obstruction in patients with preoperative urinary catheter. J Endourol2021; 35: 102–108.
61.
MitchellCRMynderseLALightnerDJ, et al. Efficacy of holmium laser enucleation of the prostate in patients with non-neurogenic impaired bladder contractility: results of a prospective trial. Urology2014; 83: 428–432.
62.
ChoS, et al. Preoperative urinary retention increased the risk of urinary retention after photoselective vaporization of the prostate. World J Men’s Health2015; 33: 182.
